Cerluten dosing & administration
Brain-derived peptide bioregulator complex containing AED, KED, AEDG, and KE peptides that promote neurogenesis through histone binding, restore dendritic spine architecture under neurotoxic conditions, and enhance cognitive recovery in stroke and brain injury patients
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team
Dosing
How much do I take?
Oral: Taken by mouth as a capsule, tablet, or liquid.
Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.
1-2 capsules (0.2 g each)
Frequency
1-2 times daily with meals
Duration
30-day intensive course; then 10-day maintenance course every 3 months
The common capsule plan used in practice for this CNS peptide supplement. A typical intensive start is 2 capsules daily for 30 days, then 2 capsules daily for 10 days every 3 months. [6]
Timing
Best time to take
Take Cerluten at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Cerluten can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Cerluten should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Example
Cerluten comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Cerluten exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Injection
Route
Cerluten is administered Oral (capsule)—no injection required
Best sites
Technique
- 01Follow the specific administration instructions for your Cerluten formulation
- 02Take or apply as directed by your healthcare provider
- 03Store properly between uses according to package instructions
Storage
Before reconstitution
Store Cerluten in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Cerluten should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Oral (capsule)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Cerluten. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Safety profile
Cerluten is a peptide extract from cerebral tissue of young animals that is not FDA-approved and lacks rigorous clinical safety data. As an undefined mixture of peptides and proteins from animal sources, quality control and batch consistency cannot be guaranteed. Potential risks include allergic reactions to animal-derived proteins, contamination with microbial pathogens or prions, and unknown long-term immunological effects. No comprehensive safety studies have been conducted in humans, and the active pharmaceutical components have never been identified or standardized. The product exists primarily in Russian and Eastern European medical markets without Western regulatory oversight.
Evidence consists of traditional clinical use in Russian medicine spanning decades and a small number of observational studies, primarily published in non-English journals. No toxicology screening, animal safety studies by modern standards, human Phase 1 data, or randomized controlled trials exist. Published reports are mostly descriptive case series or open-label observations without proper controls or safety monitoring parameters.
Common side effects
Experienced by some users
Mild headache
Transient headache during the initial days of treatment as brain neurochemistry adjusts to enhanced neuronal gene expression and modified signaling patterns.
Management: Ensure adequate hydration. Usually self-limiting within 3-5 days. Reduce dose temporarily if persistent.
Mild drowsiness
Slight fatigue or drowsiness in the first few days, particularly with the sublingual form, as neuronal activity patterns shift.
Management: Take in the morning or early afternoon. Usually resolves within the first week of use.
Mild GI discomfort
Slight nausea or stomach discomfort with oral capsule administration, common with peptide supplements.
Management: Take capsules with a small amount of food or water. Consider the sublingual form to bypass the GI tract.
Vivid dreams
Enhanced dream vividness reflecting active neuroplasticity and neural reorganization processes stimulated by the peptide complex.
Management: Generally benign and may indicate active neurogenesis. No action typically required.
Less common
- Transient sleep pattern changes
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Cerluten
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Cerluten should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
- Pinealon (EDR peptide — targeted serotonin/pineal support that complements Cerluten's broader neuronal peptide complex approach) - May be used together under medical guidance.
- Epithalon/Epithalamin (AEDG peptide — supports melatonin synthesis and neuroendocrine function alongside Cerluten's cognitive effects) - May be used together under medical guidance.
- Cortexin (brain peptide preparation — complementary neurotrophic peptide complex with overlapping but distinct mechanisms) - May be used together under medical guidance.
With medications
- Other CNS-active peptide complexes at high doses without medical guidance — potential for overlapping epigenetic effects - Use with caution—discuss with your healthcare provider.
- Strong sedatives or CNS depressants — may produce additive sedation - Use with caution—discuss with your healthcare provider.
- Immunosuppressive medications — Cerluten's component peptides have immunomodulatory properties that may interact with immunosuppression - Use with caution—discuss with your healthcare provider.
With supplements
- Multivitamins - Generally safe to take alongside Cerluten. Space doses apart if taking oral formulations to ensure optimal absorption.
- Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Published research
What the studies show
Ilina A, Khavinson V, Linkova N · 2022
Cerluten's short peptides work like molecular switches that control which genes your brain cells turn on and off, acting directly on the proteins that package your DNA. This epigenetic control is crucial because it allows damaged brain cells to reboot their protective and regenerative programs, offering hope for treating Alzheimer's disease.
Khavinson V, Diomede F, Mironova E · 2020
When human stem cells were exposed to the AEDG peptide from Cerluten, their brain-cell markers increased by 1.6 to 1.8 times, including growth-associated proteins critical for forming new neurons. The peptide worked by binding directly to the DNA-packaging proteins, showing that Cerluten acts at the fundamental genetic level to reprogram cells toward brain repair.
Kraskovskaya NA, Kukanova EO, Lin'kova NS · 2017
When Cerluten peptides were added to simulated Alzheimer's damage in the lab, one peptide restored 71% of the nerve cell connection points that had been destroyed, while another restored 20%. These connection points are where memory and thinking happen, so rebuilding them is like rewiring broken circuits in a damaged brain.
Ashapkin V, Khavinson V, Shilovsky G · 2020
A key Cerluten peptide turned on growth factors in aging cells by 3.5 to 5.6 times, activating genes linked to longevity and turning down genes that signal aging. This molecular dial-turning suggests Cerluten can reverse aging processes in brain stem cells at incredibly tiny doses.
Lin'kova NS, Drobintseva AO, Orlova OA · 2016
Every peptide in Cerluten blocked a destructive enzyme (MMP-9) that tears apart cellular machinery as we age, while boosting two key regeneration markers. Some peptides also shut down cellular death pathways, meaning Cerluten works like a multi-tool protecting aging cells from multiple directions.
2024
Marketed as a peptide dietary supplement (Cytomax capsules, 0.2 g). Commonly used in practice at 1-2 capsules once or twice daily with meals; intensive course 2 capsules/day for 30 days, then maintenance 2 capsules/day for 10 days repeated every 3 months. Not approved as a medicine in Western jurisdictions.
Head to head
Cerluten compared
Want the full picture?
The complete Cerluten research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.